About Us

Who we are

Shaping the Future of
Cancer Care

We are committed to advancing patient care by offering a proven portfolio of comprehensive genomic profiling products that help physicians make more informed care decisions. 


Through constant innovation in molecular insights, we are dedicated to working with our partners to deliver breakthroughs that improve outcomes for more individuals living with cancer and bringing them to routine cancer care every day. That’s why we foster a collaborative culture that motivates us to do our best work and be a partner in every patient’s journey. 


Our approach offers not just test results, but the highest quality insights that can help doctors match patients to more treatment options and help accelerate the development of new therapies. 

Tissue-based companion diagnostic for all solid tumors

FOUNDATIONONE® CDX

BROWSE
Blood-based companion diagnostic for all solid tumors

FOUNDATIONONE® LIQUID CDX

BROWSE
Test for hematologic malignancies, sarcomas or solid tumors

FOUNDATIONONE® HEME

BROWSE

Browse our FAQs

View commonly asked questions for providers, biopharma partners and patients.

View Publications

Browse some of our +450 peer-reviewed publications

Contact us

Can't find what you're looking for? Our client services team is available to help, Monday through Friday, 8AM - 8PM EST.